跳至主要内容
临床试验/NCT00812201
NCT00812201已完成不适用

Evaluation of Left Ventricular AutoThreshold

Boston Scientific Corporation2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2008年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
2
主要终点
The objective of this study is to collect data to characterize the performance of the LVAT feature.

研究概览

简要总结

This study will collect data on a new feature for future heart failure devices via an external non-implantable system.

详细描述

ELEVATE is an acute, prospective, multi-center, feasibility study with a randomized within patient test sequence and pulse width, designed to characterize the performance of the Left Ventricular Auto Threshold feature.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are scheduled to receive a CRT-P or CRT-D, based on physician discretion
  • Patients who are willing and capable of participating in all testing associated with this study
  • Patients who are 18 or above, or of legal age to give informed consent specific to state and national law

排除标准

  • Patients who have, or are scheduled to receive a unipolar LV pace/sense lead to be used with the CRT-P/CRT-D device, unless the patient has any commercially available epicardial leads with at least two electrodes (from one or more leads)
  • Patients with pre-existing leads other than those specified in this investigational plan (unless the Investigator intends to replace them with permitted leads)
  • Patients with a pre-existing unipolar pacemaker that will not be explanted/abandoned
  • Patients enrolled in any concurrent study, without Boston Scientific CRM written approval, that may confound the results of this study
  • Patients with a prosthetic mechanical tricuspid heart valve
  • Women who are pregnant

结局指标

主要结局

The objective of this study is to collect data to characterize the performance of the LVAT feature.

时间窗: Implant

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验